Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
-
ZenaTech’s ZenaDrone Multipurpose AI Drone Applies for FAA Part 137 Crop Sprayer Certification for Agricultural and Wildfire Industry Use
-
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
-
Ranchero Completes Debt Settlement Transaction
-
Prairie Operating Co. Completes Shelduck South Pad, Prepares for New Developments
-
Opera to Participate in Upcoming Investor Conference
-
Global Times: Nearly 80% of foreign respondents show confidence in China's development prospect in first survey on China's international image
-
MuaSim.vn Announces Comprehensive SIM Card Solutions for Diverse Needs
-
Dr. Caroline Joan ("Kay") S. Picart Announces Forthcoming Book: Countering Jihadi-Cool: Narrative, Law, Culture and Philosophy Against Global Jihad
-
FINAL DAYS OF DSF: LAST CHANCE TO EXPERIENCE THE EPIC 30TH EDITION IN ITS CLOSING WEEKEND
-
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
-
Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones
-
Alliance Witan PLC - Net Asset Value
-
Galaxy Payroll: Driving Innovation in Human Resources Management
-
Revolutionizing Psychology: Asian Conference on Applied Psychology 2025 Unveils VR Networking and Global Collaboration
-
First Phosphate Reports University Research Reports Relating to the Geological Characterization of its Three Bégin-Lamarche Phosphate Zones
-
Global Competition Launches to Drug 'Undruggable' Cancer Target
-
Cooler Master Launches the CH351: 3D Surround Sound Wireless Gaming Headset for Total Immersion
-
Y-mAbs Provides Strategic Business Update and 2025 Priorities
-
NeoGenomics Announces Chief Executive Officer Succession
-
HBT Financial, Inc. to Announce Fourth Quarter 2024 Financial Results on January 22, 2025
-
Five Star Franchising brands named 2025 Top Franchises by Franchise Business Review
-
U-Haul Opens New and Improved Full-Service Center in Schofield
-
Lumira Ventures Announces Promotion of Suman Rao to Principal
-
Gold Terra Announces Start of 2025 Drilling Program Targeting High-Grade Gold in the Campbell Shear, Con Mine Option Property, NWT
-
Olive Resource Capital Announces December 31, 2024 NAV of C$0.064 per Share
-
G2 Names INE 2025 Networking and Cybersecurity Training Leader
-
Compass Pathways Announces Pricing of Underwritten Offering
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC
-
Specificity Eyes 2025 for Serious Growth
-
Tilray Brands Reports Q2 2025 Financial Results
-
Belharra Therapeutics Announces Appointment of Sean Buchanan, Ph.D., as Chief Scientific Officer and Retirement of Gary O’Neill, Ph.D.
-
BioCryst Announces Preliminary Full Year 2024 ORLADEYO® (berotralstat) Net Revenue of $437 Million (+34 percent y-o-y)
-
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update
-
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
-
MD Logic Health® Introduces Cool: A Breakthrough In Women's Hormonal Health!
-
Nickel Sulphate Futures Now Live for Trading on Abaxx Exchange
-
New Book Unveils a Neuroscience-Based Framework to Break Free from Divorce Indecision in Just 30 Days
-
Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes
-
Bio-Path Holdings Provides 2025 Clinical and Operational Update
-
Lantronix Names Brent Stringham as CFO
-
Plymouth Industrial REIT Provides Activity Update for Fourth Quarter 2024
-
Aircastle Announces Third Quarter 2024 Results
-
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2025
-
Marengo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
-
Empowering the Next Generation: Aurora Announces German Internship Program
-
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
-
U.S. Energy Corp. Announces Recent AcquisitionTargeting Industrial Gas Production
